登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Reactogenicity after rAd5 boost by study group.
Reactogenicity after rAd5 boost by study group.
收藏
NIAID Data Ecosystem
2026-03-07 收录
疫苗反应原性
临床试验安全性
数据链接：
https://figshare.com/articles/dataset/_Reactogenicity_after_rAd5_boost_by_study_group_/407651
数据链接
链接失效反馈
官方服务：
问题咨询
购买咨询
在线客服
NEW
资源简介：
Reactogenicity after rAd5 boost by study group.
应用场景：
创建时间：
2011-09-12
相关数据集
Demographics and baseline characteristics of the safety population.
临床试验安全性
受试者特征
Demographics and baseline characteristics of the safety population.
Figshare
2021-11-18 更新
4
0
Local and Solicited Systemic Reactogenicity.
疫苗反应原性
药物安全性评估
Local and Solicited Systemic Reactogenicity.
NIAID Data Ecosystem
4
0
Summary of treatment emergent adverse events (TEAE), overall and by study arm.
临床试验安全性
药物不良反应监测
Summary of treatment emergent adverse events (TEAE), overall and by study arm.
NIAID Data Ecosystem
3
0
Adverse events observed in the 27 patients treated at the recommended dose.
药物不良反应监测
临床试验安全性
Adverse events observed in the 27 patients treated at the recommended dose.
Figshare
2016-12-20 更新
4
0
Identification of Biomarkers of Vaccine Reactogenicity. Identification of Biomarkers of Vaccine Reactogenicity
疫苗反应原性
转录组生物标志物
Systems vaccinology approaches have been used to successfully define early signatures of the vaccine-induced immune response. However, the possibility that transcriptomics can also predict vaccine rea
NIAID Data Ecosystem
3
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广
